Global Rotavirus Vaccine Market 2022: Overview, Opportunities, in-Depth Analysis and Forecasts 2021

Pune, India -- (SBWire) -- 06/02/2018 --Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease. Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.

Rotavirus is a double-stranded RNA virus of the family Reoviridae and is transmitted through the faecal-oral route. It infects the cell lining of the small intestine and causes gastroenteritis. According to National Center for Biotechnology Information, rotavirus related diarrhoea was responsible for killing about 600,000 children in 2015, with more than 80% of all rotavirus-related deaths occurring in in South Asia and sub-Saharan Africa. Rotavirus-related deaths represent approximately 5% of all deaths in children younger than 5 years of age worldwide. Almost every child in the world is infected with rotavirus at least once by the age of five.

Key Players:
Bharat Biotech, Merck & Co., Inc., GlaxoSmithKline plc., Multinational pharmaceutical drug company and others

For Sample Copy of this report: https://www.healthcareintelligencemarkets.com/request_sample.php?id=15231

The major geographical regions which include, North America, Asia Pacific, Europe, the Middle East & Africa and Latin America are studied. Top manufacturers from all these regions are studied to help give a better picture of the market investment. Production, price, capacity, revenue and many such important data is been discussed with precise data.

This report presents a 360-degree overview of the competitive scenario of the Global Rotavirus Vaccine market. The report includes massive data relating to the recent product and technological developments observed in the market, complete with an analysis of the impact of these advancements on the market's future development. The research report analyzes the global Rotavirus Vaccine market in a detailed manner by explaining the key aspects of the market that are expected to have a quantifiable influence on its developmental prospects over the forecast period.

Avail 30% Discount on this Report@: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=15231

The report takes a close and analytical look at the various companies that strive for a higher share of the global Rotavirus Vaccine market. For this purpose, a section dedicated to company profiles has been included in the report. The profiling of the leading players is done in order to judge the current competitive scenario. The competitive landscape is assessed by taking into consideration many important factors such as business growth, recent developments, product pipeline, and others.

Table of Contents:
Global Rotavirus Vaccine Market Research Report 2018-2023
Chapter 1 Rotavirus Vaccine Market Overview
Chapter 2 Global Economic Impact
Chapter 3 Competition by Manufacturers
Chapter 4 Production, Revenue (Value) by Region (2018-2023)
Chapter 5 Supply (Production), Consumption, Export, Import by Regions (2018-2023)
Chapter 6 Production, Revenue (Value), Price Trend by Type
Chapter 7 Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis
Chapter 12 Market Forecast (2017-2021)
Chapter 13 Appendix

Get Complete Report@: https://www.healthcareintelligencemarkets.com/reports/Global-Rotavirus-Vaccine-Market-Research-Report-2017-15231